BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet 2021;398:786-802. [PMID: 34175022 DOI: 10.1016/S0140-6736(21)00519-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 88] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wei YY, Zhang YN, Wang H, Ga Y, Fan Y, Wang Q, Gu JH, Zhang XY, Gong XH, Hao ZH. Mori fructus aqueous extracts attenuate carbon tetrachloride-induced renal injury via the Nrf2 pathway and intestinal flora. Ecotoxicol Environ Saf 2022;245:114118. [PMID: 36174321 DOI: 10.1016/j.ecoenv.2022.114118] [Reference Citation Analysis]
2 Perry LM, Morken V, Peipert JD, Yanez B, Garcia SF, Barnard C, Hirschhorn LR, Linder JA, Jordan N, Ackermann RT, Harris A, Kircher S, Mohindra N, Aggarwal V, Frazier R, Coughlin A, Bedjeti K, Weitzel M, Nelson EC, Elwyn G, Van Citters AD, O'Connor M, Cella D. Patient-Reported Outcome Dashboards Within the Electronic Health Record to Support Shared Decision-making: Protocol for Co-design and Clinical Evaluation With Patients With Advanced Cancer and Chronic Kidney Disease. JMIR Res Protoc 2022;11:e38461. [PMID: 36129747 DOI: 10.2196/38461] [Reference Citation Analysis]
3 Brito JS, Reis D, Silva G, Fonseca L, Ribeiro M, Chermut T, Oliveira L, Borges NA, Ribeiro-Alves M, Mafra D. Bicycle ergometer exercise during hemodialysis and its impact on quality of life, aerobic fitness and dialysis adequacy: A pilot study. Complement Ther Clin Pract 2022;49:101669. [PMID: 36152526 DOI: 10.1016/j.ctcp.2022.101669] [Reference Citation Analysis]
4 Kuma A, Kato A. Lifestyle-Related Risk Factors for the Incidence and Progression of Chronic Kidney Disease in the Healthy Young and Middle-Aged Population. Nutrients 2022;14:3787. [DOI: 10.3390/nu14183787] [Reference Citation Analysis]
5 Liu Y, Wang Y, Chen S, Bai L, Xie X, Zhang L, Wang X. Investigation into the effect and mechanism of dapagliflozin against renal interstitial fibrosis based on transcriptome and network pharmacology. Int Immunopharmacol 2022;112:109195. [PMID: 36070627 DOI: 10.1016/j.intimp.2022.109195] [Reference Citation Analysis]
6 Paul Owens E, Grania Healy H, Andrew Vesey D, Elizabeth Hoy W, Carolyn Gobe G. Targeted biomarkers of progression in chronic kidney disease. Clin Chim Acta 2022:S0009-8981(22)01283-9. [PMID: 36041551 DOI: 10.1016/j.cca.2022.08.025] [Reference Citation Analysis]
7 Alnamshan MM. Antioxidant extract of black rice prevents renal dysfunction and renal fibrosis caused by ethanol-induced toxicity. Braz J Biol 2022;82:e261874. [PMID: 36000692 DOI: 10.1590/1519-6984.261874] [Reference Citation Analysis]
8 Satarug S, Vesey DA, Gobe GC. Dose–Response Analysis of the Tubular and Glomerular Effects of Chronic Exposure to Environmental Cadmium. IJERPH 2022;19:10572. [DOI: 10.3390/ijerph191710572] [Reference Citation Analysis]
9 Mitsiou M, Dimitros E, Roumeliotis S, Liakopoulos V, Kouidi E, Deligiannis A. Effects of a Combined Intradialytic Exercise Training Program and Music on Cardiac Autonomic Nervous System Activity in Hemodialysis Patients. Life (Basel) 2022;12:1276. [PMID: 36013455 DOI: 10.3390/life12081276] [Reference Citation Analysis]
10 Wang Y, Liu H, Ren L, Suo P, Zou L, Zhang Y, Yu X, Zhao Y. Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway. Front Pharmacol 2022;13:964370. [DOI: 10.3389/fphar.2022.964370] [Reference Citation Analysis]
11 Chen J, Liu Q, He J, Li Y. Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target. Front Immunol 2022;13:958790. [DOI: 10.3389/fimmu.2022.958790] [Reference Citation Analysis]
12 Satarug S, Gobe GC, Vesey DA. Multiple Targets of Toxicity in Environmental Exposure to Low-Dose Cadmium. Toxics 2022;10:472. [PMID: 36006151 DOI: 10.3390/toxics10080472] [Reference Citation Analysis]
13 Dong L, Xu W, Deng Y, Tan J, Qin W. Efficacy and safety of potassium binders in the treatment of patients with chronic kidney disease and hyperkalemia. Eur J Pharmacol 2022;931:175174. [PMID: 35964658 DOI: 10.1016/j.ejphar.2022.175174] [Reference Citation Analysis]
14 Kwon YJ, Park K, Lee JH. Low-protein diet is inversely related to the incidence of chronic kidney disease in middle-aged and older adults: results from a community-based prospective cohort study. Eur J Nutr 2022. [PMID: 35947164 DOI: 10.1007/s00394-022-02981-1] [Reference Citation Analysis]
15 Zheng J, Wu X, Dai J, Pan C, Shi H, Liu T, Jiao Z. Aberrant brain gray matter and functional networks topology in end stage renal disease patients undergoing maintenance hemodialysis with cognitive impairment. Front Neurosci 2022;16:967760. [DOI: 10.3389/fnins.2022.967760] [Reference Citation Analysis]
16 Jalandra R, Dhar R, Pethusamy K, Sharma M, Karmakar S. Dysbiosis: Gut feeling. F1000Res 2022;11:911. [DOI: 10.12688/f1000research.122429.1] [Reference Citation Analysis]
17 Wang YN, Zhang ZH, Liu HJ, Guo ZY, Zou L, Zhang YM, Zhao YY. Integrative phosphatidylcholine metabolism through phospholipase A2 in rats with chronic kidney disease. Acta Pharmacol Sin 2022. [PMID: 35922553 DOI: 10.1038/s41401-022-00947-x] [Reference Citation Analysis]
18 Rubio-Aliaga I, Krapf R. Phosphate intake, hyperphosphatemia, and kidney function. Pflugers Arch 2022;474:935-47. [PMID: 35511366 DOI: 10.1007/s00424-022-02691-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Li Y, Duan R. Nanostructures with at least one dimension in ultra-small size for the treatment of acute kidney injury. Giant 2022;11:100111. [DOI: 10.1016/j.giant.2022.100111] [Reference Citation Analysis]
20 Zheng J, Sun Q, Wu X, Dou W, Pan J, Jiao Z, Liu T, Shi H. Brain Micro-Structural and Functional Alterations for Cognitive Function Prediction in the End-Stage Renal Disease Patients Undergoing Maintenance Hemodialysis. Acad Radiol 2022:S1076-6332(22)00365-8. [PMID: 35879210 DOI: 10.1016/j.acra.2022.06.019] [Reference Citation Analysis]
21 Luo W, Gong L, Chen X, Gao R, Peng B, Wang Y, Luo T, Yang Y, Kang B, Peng C, Ma L, Mei M, Liu Z, Li Q, Yang S, Wang Z, Hu J. Lifestyle and chronic kidney disease: A machine learning modeling study. Front Nutr 2022;9:918576. [DOI: 10.3389/fnut.2022.918576] [Reference Citation Analysis]
22 Wu HHL, Goldys EM, Pollock CA, Saad S. Exfoliated Kidney Cells from Urine for Early Diagnosis and Prognostication of CKD: The Way of the Future? Int J Mol Sci 2022;23:7610. [PMID: 35886957 DOI: 10.3390/ijms23147610] [Reference Citation Analysis]
23 Liu X, Deng R, Chen Y, Huang S, Lu J, Zheng L, Xiong G, Li S. Jian-Pi-Yi-Shen Formula Improves Adenine-Induced Chronic Kidney Disease via Regulating Tryptophan Metabolism and Aryl Hydrocarbon Receptor Signaling. Front Pharmacol 2022;13:922707. [DOI: 10.3389/fphar.2022.922707] [Reference Citation Analysis]
24 Yu S, Long Y, Li D, Shi A, Deng J, Ma Y, Wen J, Li X, Zhang Y, Liu S, Wan J, Li N, Guo J. Natural essential oils efficacious in internal organs fibrosis treatment: mechanisms of action and application perspectives. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106339] [Reference Citation Analysis]
25 Suo XG, Wang F, Xu CH, He XY, Wang JN, Zhang Y, Ni WJ, Lu H, Ji ML, He Y, Xie SS, Yang YR, Wen JG, Jin J, Gong Q, Li J, Liu MM, Meng XM. Targeted inhibition of TGF-β type I receptor by AZ12601011 protects against kidney fibrosis. Eur J Pharmacol 2022;:175116. [PMID: 35780825 DOI: 10.1016/j.ejphar.2022.175116] [Reference Citation Analysis]
26 Lin C, Li Y, Wang Y, Chang W. Higher Neutrophil-To-Lymphocyte Ratio Was Associated with Increased Risk of Chronic Kidney Disease in Overweight/Obese but Not Normal-Weight Individuals. IJERPH 2022;19:8077. [DOI: 10.3390/ijerph19138077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Deng X, Gao B, Wang F, Zhao MH, Wang J, Zhang L. Red Blood Cell Distribution Width Is Associated With Adverse Kidney Outcomes in Patients With Chronic Kidney Disease. Front Med (Lausanne) 2022;9:877220. [PMID: 35755057 DOI: 10.3389/fmed.2022.877220] [Reference Citation Analysis]
28 Mantovani A, Lombardi R, Cattazzo F, Zusi C, Cappelli D, Dalbeni A. MAFLD and CKD: An Updated Narrative Review. IJMS 2022;23:7007. [DOI: 10.3390/ijms23137007] [Reference Citation Analysis]
29 Bian J, Liebert A, Bicknell B, Chen XM, Huang C, Pollock CA. Faecal Microbiota Transplantation and Chronic Kidney Disease. Nutrients 2022;14:2528. [PMID: 35745257 DOI: 10.3390/nu14122528] [Reference Citation Analysis]
30 Wei X, Wang Y, Weng J, Lao Y, Deng R, Lu J, Yang S, Liu X. Combination of Perindopril Erbumine and Huangqi-Danshen Decoction Protects Against Chronic Kidney Disease via Sirtuin3/Mitochondrial Dynamics Pathway. Evid Based Complement Alternat Med 2022;2022:5812105. [PMID: 35677375 DOI: 10.1155/2022/5812105] [Reference Citation Analysis]
31 Dehghani A, Alishavandi S, Nourimajalan N, Fallahzadeh H, Rahmanian V. Prevalence of chronic kidney diseases and its determinants among Iranian adults: results of the first phase of Shahedieh cohort study. BMC Nephrol 2022;23:203. [PMID: 35681145 DOI: 10.1186/s12882-022-02832-5] [Reference Citation Analysis]
32 Dai J, Li C, Zhao L, Guan C, Yang C, Zhang N, Zhou B, Zhang Y, Wang L, Jiang W, Luo C, Xu Y. Scutellarin protects the kidney from ischemia/reperfusion injury by targeting Nrf2. Nephrology (Carlton) 2022. [PMID: 35638402 DOI: 10.1111/nep.14069] [Reference Citation Analysis]
33 Langham RG, Kalantar-zadeh K, Bonner A, Balducci A, Hsiao L, Kumaraswami LA, Laffin P, Liakopoulos V, Saadi G, Tantisattamo E, Ulasi I, Lui S. Saúde dos rins para todos: preenchendo a lacuna de educação e conhecimento sobre a saúde renal. Braz J Nephrol . [DOI: 10.1590/2175-8239-jbn-2022-0027pt] [Reference Citation Analysis]
34 Langham RG, Kalantar-Zadeh K, Bonner A, Balducci A, Hsiao LL, Kumaraswami LA, Laffin P, Liakopoulos V, Saadi G, Tantisattamo E, Ulasi I, Lui SF. Kidney health for all: bridging the gap in kidney health education and literacy. J Bras Nefrol 2022:S0101-28002022005031401. [PMID: 35640026 DOI: 10.1590/2175-8239-JBN-2022-0027en] [Reference Citation Analysis]
35 Panchal SK, John OD, Mathai ML, Brown L. Anthocyanins in Chronic Diseases: The Power of Purple. Nutrients 2022;14:2161. [PMID: 35631301 DOI: 10.3390/nu14102161] [Reference Citation Analysis]
36 Langham RG, Kalantar-Zadeh K, Bonner A, Balducci A, Hsiao LL, Kumaraswami LA, Laffin P, Liakopoulos V, Saadi G, Tantisattamo E, Ulasi I, Lui SF. Kidney health for all: bridging the gap in kidney health education and literacy. Braz J Med Biol Res 2022;55:e12161. [PMID: 35584454 DOI: 10.1590/1414-431X2022e12161] [Reference Citation Analysis]
37 De Nicola L, Cozzolino M, Genovesi S, Gesualdo L, Grandaliano G, Pontremoli R. Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease? J Nephrol 2022. [PMID: 35583597 DOI: 10.1007/s40620-022-01336-7] [Reference Citation Analysis]
38 Lightfoot CJ, Wilkinson TJ, Hadjiconstantinou M, Graham-brown M, Barratt J, Brough C, Burton JO, Hainsworth J, Johnson V, Martinez M, Nixon AC, Pursey V, Schreder S, Vadaszy N, Wilde L, Willingham F, Young HML, Yates T, Davies MJ, Smith AC. The co-development of ‘My Kidneys & Me’: a digital self-management programme for people with chronic kidney disease (Preprint). Journal of Medical Internet Research. [DOI: 10.2196/39657] [Reference Citation Analysis]
39 Pham KO, Hara A, Tsujiguchi H, Suzuki K, Suzuki F, Miyagi S, Kannon T, Sato T, Hosomichi K, Tsuboi H, Nguyen TTT, Shimizu Y, Kambayashi Y, Nakamura M, Takazawa C, Nakamura H, Hamagishi T, Shibata A, Konoshita T, Tajima A, Nakamura H. Association between Vitamin Intake and Chronic Kidney Disease According to a Variant Located Upstream of the PTGS1 Gene: A Cross-Sectional Analysis of Shika Study. Nutrients 2022;14:2082. [PMID: 35631221 DOI: 10.3390/nu14102082] [Reference Citation Analysis]
40 Langham RG, Kalantar-Zadeh K, Bonner A, Balducci A, Hsiao LL, Kumaraswami LA, Laffin P, Liakopoulos V, Saadi G, Tantisattamo E, Ulasi I, Lui SF; World Kidney Day Joint Steering Committee . Kidney Health for All: Bridging the Gap in Kidney Health Education and Literacy. Am J Hypertens 2022;35:470-7. [PMID: 35536290 DOI: 10.1093/ajh/hpac025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Neuen BL, Oshima M, Agarwal R, Arnott C, Cherney DZ, Edwards R, Langkilde AM, Mahaffey KW, McGuire DK, Neal B, Perkovic V, Pong A, Sabatine MS, Raz I, Toyama T, Wanner C, Wheeler DC, Wiviott SD, Zinman B, Heerspink HJL. Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials. Circulation 2022;145:1460-70. [PMID: 35394821 DOI: 10.1161/CIRCULATIONAHA.121.057736] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
42 Gao Z, Zhang C, Peng F, Chen Q, Zhao Y, Chen L, Wang X, Chen X. Hypoxic mesenchymal stem cell-derived extracellular vesicles ameliorate renal fibrosis after ischemia-reperfusion injure by restoring CPT1A mediated fatty acid oxidation. Stem Cell Res Ther 2022;13:191. [PMID: 35526054 DOI: 10.1186/s13287-022-02861-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Lin L, Wang X, Niu M, Wu Q, Wang H, Zu Y, Wang W. Biomimetic epithelium/endothelium on chips. Engineered Regeneration 2022. [DOI: 10.1016/j.engreg.2022.05.001] [Reference Citation Analysis]
44 Kwon YJ, Lee HS, Park GE, Kim HM, Lee JJ, Kim WJ, Lee JW. The Association Between Total Protein Intake and All-Cause Mortality in Middle Aged and Older Korean Adults With Chronic Kidney Disease. Front Nutr 2022;9:850109. [PMID: 35445069 DOI: 10.3389/fnut.2022.850109] [Reference Citation Analysis]
45 Kwon Y, Lee HS, Park GE, Lee J. Association Between Dietary Fiber Intake and All-Cause and Cardiovascular Mortality in Middle Aged and Elderly Adults With Chronic Kidney Disease. Front Nutr 2022;9:863391. [DOI: 10.3389/fnut.2022.863391] [Reference Citation Analysis]
46 Guerreiro Í, Ferreira-pêgo C, Carregosa D, Santos CN, Menezes R, Fernandes AS, Costa JG. Polyphenols and Their Metabolites in Renal Diseases: An Overview. Foods 2022;11:1060. [DOI: 10.3390/foods11071060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
47 Beimler J. [New aspects of pharmacological nephroprotection]. Internist (Berl) 2022. [PMID: 35380212 DOI: 10.1007/s00108-022-01297-w] [Reference Citation Analysis]
48 Li Q, Wu J, Huang J, Hu R, You H, Liu L, Wang D, Wei L. Paeoniflorin Ameliorates Skeletal Muscle Atrophy in Chronic Kidney Disease via AMPK/SIRT1/PGC-1α-Mediated Oxidative Stress and Mitochondrial Dysfunction. Front Pharmacol 2022;13:859723. [PMID: 35370668 DOI: 10.3389/fphar.2022.859723] [Reference Citation Analysis]
49 Montenegro J, Klein MRST, Bregman R, Prado CM, Barreto Silva MI. Osteosarcopenia in patients with non-dialysis dependent chronic kidney disease. Clinical Nutrition 2022. [DOI: 10.1016/j.clnu.2022.04.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
50 Pöhlmann J, Bergenheim K, Garcia Sanchez JJ, Rao N, Briggs A, Pollock RF. Modeling Chronic Kidney Disease in Type 2 Diabetes Mellitus: A Systematic Literature Review of Models, Data Sources, and Derivation Cohorts. Diabetes Ther 2022;13:651-77. [PMID: 35290625 DOI: 10.1007/s13300-022-01208-0] [Reference Citation Analysis]
51 Saifi MA, Godugu C. Copper chelation therapy inhibits renal fibrosis by modulating copper transport proteins. Biofactors 2022. [PMID: 35322483 DOI: 10.1002/biof.1837] [Reference Citation Analysis]
52 Zhou S, Yin X, Yuan J, Liang Z, Song J, Li Y, Peng C, Hylands PJ, Zhao Z, Xu Q. Antifibrotic activities of Scutellariae Radix extracts and flavonoids: Comparative proteomics reveals distinct and shared mechanisms. Phytomedicine 2022;100:154049. [PMID: 35397287 DOI: 10.1016/j.phymed.2022.154049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Huang Y, Xin W, Xiong J, Yao M, Zhang B, Zhao J. The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease. Front Pharmacol 2022;13:837500. [DOI: 10.3389/fphar.2022.837500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
54 Hornig C, Apel C, Ficociello LH, Kendzia D, Anger M, Bowry SK. Switching from high-flux dialysis to hemodiafiltration: Cost-consequences for patients, providers, and payers. Semin Dial 2022. [PMID: 35301753 DOI: 10.1111/sdi.13075] [Reference Citation Analysis]
55 Langham RG, Kalantar-Zadeh K, Bonner A, Balducci A, Hsiao LL, Kumaraswami LA, Laffin P, Liakopoulos V, Saadi G, Tantisattamo E, Ulasi I, Lui SF. Kidney Health for All: Bridging the Gap in Kidney Health Education and Literacy. Can J Kidney Health Dis 2022;9:20543581221085075. [PMID: 35284081 DOI: 10.1177/20543581221085075] [Reference Citation Analysis]
56 Langham RG, Kalantar-zadeh K, Bonner A, Balducci A, Hsiao L, Kumaraswami LA, Laffin P, Liakopoulos V, Saadi G, Tantisattamo E, Ulasi I, Lui S, Langham RG, Kalantar-zadeh K, Balducci A, Hsiao L, Kumaraswami L, Laffin P, Liakopoulos V, Saadi G, Ulasi I, Lui S; For the World Kidney Day Joint Steering Committee. Kidney health for all: bridging the gap in kidney health education and literacy. J Nephrol. [DOI: 10.1007/s40620-022-01290-4] [Reference Citation Analysis]
57 Langham RG, Kalantar-Zadeh K, Bonner A, Balducci A, Hsiao LL, Kumaraswami LA, Laffin P, Liakopoulos V, Saadi G, Tantisattamo E, Ulasi I, Lui SF; World Kidney Day Joint Steering Committee. Kidney Health for All: Bridging the Gap in Kidney Health Education and Literacy. Am J Nephrol 2022;53:87-95. [PMID: 35287131 DOI: 10.1159/000522553] [Reference Citation Analysis]
58 Langham RG, Kalantar-Zadeh K, Bonner A, Balducci A, Hsiao LL, Kumaraswami LA, Laffin P, Liakopoulos V, Saadi G, Tantisattamo E, Ulasi I, Lui SF; World Kidney Day Joint Steering Committee. Kidney health for all: Bridging the gap in kidney health education and literacyta. J Ren Care 2022. [PMID: 35266639 DOI: 10.1111/jorc.12414] [Reference Citation Analysis]
59 Zhou X, Zhong X, Duan L. Integration of Artificial Intelligence And Multi-omics in Kidney Diseases. Fundamental Research 2022. [DOI: 10.1016/j.fmre.2022.01.037] [Reference Citation Analysis]
60 Lu C, Chen H, Wang C, Yang F, Li J, Liu H, Chen G. An Emerging Role of TIM3 Expression on T Cells in Chronic Kidney Inflammation. Front Immunol 2021;12:798683. [PMID: 35154075 DOI: 10.3389/fimmu.2021.798683] [Reference Citation Analysis]
61 Skalsky K, Shiyovich A, Steinmetz T, Kornowski R. Chronic Renal Failure and Cardiovascular Disease: A Comprehensive Appraisal. J Clin Med 2022;11:1335. [PMID: 35268426 DOI: 10.3390/jcm11051335] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Chou Y, Chen Y, Chen J, Tarng D, Lin C, Li S. Baseline Peritoneal Membrane Transport Characteristics Are Associated with Peritonitis Risk in Incident Peritoneal Dialysis Patients. Membranes 2022;12:276. [DOI: 10.3390/membranes12030276] [Reference Citation Analysis]
63 Langham RG, Kalantar‐zadeh K, Bonner A, Balducci A, Hsiao L, Kumaraswami LA, Laffin P, Liakopoulos V, Saadi G, Tantisattamo E, Ulasi I, Lui S; The World Kidney Day Joint Steering Committee. Kidney health for all: Bridging the gap in kidney health education and literacy. Nephrology. [DOI: 10.1111/nep.14027] [Reference Citation Analysis]
64 Kawabe M, Nakashima A, Yamamoto I, Ohkido I, Yokoo T, Urashima M. Higher Soluble ACE2 Levels and Increased Risk of Infection-Related Hospitalization in Patients on Maintenance Hemodialysis. Front Med (Lausanne) 2022;9:791284. [PMID: 35155493 DOI: 10.3389/fmed.2022.791284] [Reference Citation Analysis]
65 Sharma M, Singh V, Sharma R, Koul A, Mccarthy ET, Savin VJ, Joshi T, Srivastava T. Glomerular Biomechanical Stress and Lipid Mediators during Cellular Changes Leading to Chronic Kidney Disease. Biomedicines 2022;10:407. [DOI: 10.3390/biomedicines10020407] [Reference Citation Analysis]
66 Langham RG, Kalantar-zadeh K, Bonner A, Balducci A, Hsiao L, Kumaraswami LA, Laffin P, Liakopoulos V, Saadi G, Tantisattamo E, Ulasi I, Lui S. Kidney health for all: bridging the gap in kidney health education and literacy. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.02.004] [Reference Citation Analysis]
67 Langham RG, Kalantar-zadeh K, Bonner A, Balducci A, Hsiao L, Kumaraswami LA, Laffin P, Liakopoulos V, Saadi G, Tantisattamo E, Ulasi I, Lui S, Langham RG, Kalantar-zadeh K, Balducci A, Hsiao L, Kumaraswami L, Laffin P, Liakopoulos V, Saadi G, Ulasi I, Lui S. Kidney Health For All: Bridging the Gap in Kidney Health Education and Literacy. Kidney Medicine 2022. [DOI: 10.1016/j.xkme.2022.100436] [Reference Citation Analysis]
68 Liu M, Wang W, Wang J, Fang C, Liu T. Z-Guggulsterone alleviates renal fibrosis by mitigating G2/M cycle arrest through Klotho/p53 signaling. Chemico-Biological Interactions 2022. [DOI: 10.1016/j.cbi.2022.109846] [Reference Citation Analysis]
69 Langham RG, Kalantar-zadeh K, Bonner A, Balducci A, Hsiao L, Kumaraswami LA, Laffin P, Liakopoulos V, Saadi G, Tantisattamo E, Ulasi I, Lui S, Langham RG, Kalantar-zadeh K, Ab, Hsiao L, Kumaraswami L, Laffin P, Liakopoulos V, Saadi G, Ulasi I, Lui S. Kidney health for all: bridging the gap in kidney health education and literacy. Kidney International 2022. [DOI: 10.1016/j.kint.2021.12.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
70 Li N, Zhou G, Zheng Y, Zhou E, He W, Sun W, Zhang L. Development and validation of a novel nomogram to predict overall survival of patients with moderate to severe chronic kidney disease. Ren Fail 2022;44:241-9. [PMID: 35166166 DOI: 10.1080/0886022X.2022.2032744] [Reference Citation Analysis]
71 Zhao Q, Nooren SJL, Zijlstra LE, Westenberg JJM, Kroft LJM, Jukema JW, Berkhout-byrne NC, Rabelink TJ, van Zonneveld AJ, van Buren M, Mooijaart SP, Bijkerk R. Circulating miRNAs and Vascular Injury Markers Associate with Cardiovascular Function in Older Patients Reaching End-Stage Kidney Disease. ncRNA 2022;8:2. [DOI: 10.3390/ncrna8010002] [Reference Citation Analysis]
72 Kachimanga C, Williams AJ, Bangura M, Lado M, Kanawa S, Lavallie D, Mhango M, Wurie HI, Rodriguez MP. High Prevalence of Chronic Kidney Disease Among People Living with Hypertension in Rural Sierra Leone: A Cross-Sectional Study. Int J Nephrol Renovasc Dis 2021;14:459-74. [PMID: 34992425 DOI: 10.2147/IJNRD.S342099] [Reference Citation Analysis]
73 Kalantar-Zadeh K, Lockwood MB, Rhee CM, Tantisattamo E, Andreoli S, Balducci A, Laffin P, Harris T, Knight R, Kumaraswami L, Liakopoulos V, Lui SF, Kumar S, Ng M, Saadi G, Ulasi I, Tong A, Li PK. Patient-centred approaches for the management of unpleasant symptoms in kidney disease. Nat Rev Nephrol 2022. [PMID: 34980890 DOI: 10.1038/s41581-021-00518-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 11.0] [Reference Citation Analysis]
74 Lee H, Ji SY, Hwangbo H, Kim MY, Kim DH, Park BS, Park JH, Lee BJ, Kim GY, Jeon YJ, Choi YH. Protective Effect of Gamma Aminobutyric Acid against Aggravation of Renal Injury Caused by High Salt Intake in Cisplatin-Induced Nephrotoxicity. Int J Mol Sci 2022;23:502. [PMID: 35008928 DOI: 10.3390/ijms23010502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Tantisattamo E, Hanna RM, Kalantar-Zadeh K. Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era. Curr Opin Nephrol Hypertens 2022;31:1-5. [PMID: 34846310 DOI: 10.1097/MNH.0000000000000758] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Tantisattamo E, Kalantar-Zadeh K, Molnar MZ. Nutritional and dietary interventions to prolong renal allograft survival after kidney transplantation. Curr Opin Nephrol Hypertens 2022;31:6-17. [PMID: 34750333 DOI: 10.1097/MNH.0000000000000757] [Reference Citation Analysis]
77 Song Y, Li X, Shi D, Sun T, Liu W, Li X, Qiao S, Chen X, Guo Y, Li J. A senolysis-based theragnostic prodrug strategy towards chronic renal failure. Chem Sci . [DOI: 10.1039/d2sc03525a] [Reference Citation Analysis]
78 Kalantar-Zadeh K, Rhee CM, Joshi S, Brown-Tortorici A, Kramer HM. Medical nutrition therapy using plant-focused low-protein meal plans for management of chronic kidney disease in diabetes. Curr Opin Nephrol Hypertens 2022;31:26-35. [PMID: 34750331 DOI: 10.1097/MNH.0000000000000761] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Fang L, Du Y, Rao X. A Survey Study on Soy Food Consumption in Patients with Chronic Kidney Diseases. Inquiry 2022;59:469580221093450. [PMID: 35435748 DOI: 10.1177/00469580221093450] [Reference Citation Analysis]
80 Cho E, Choi SJ, Kang DH, Kalantar-Zadeh K, Ko GJ. Revisiting glomerular hyperfiltration and examining the concept of high dietary protein-related nephropathy in athletes and bodybuilders. Curr Opin Nephrol Hypertens 2022;31:18-25. [PMID: 34846311 DOI: 10.1097/MNH.0000000000000755] [Reference Citation Analysis]
81 Ma G, Chen F, Liu Y, Zheng L, Jiang X, Tian H, Wang X, Song X, Yu Y, Wang D. Nur77 ameliorates age-related renal tubulointerstitial fibrosis by suppressing the TGF-β/Smads signaling pathway. FASEB J 2022;36:e22124. [PMID: 34972249 DOI: 10.1096/fj.202101332R] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Kolb H, Kempf K, Röhling M, Lenzen-Schulte M, Schloot NC, Martin S. Ketone bodies: from enemy to friend and guardian angel. BMC Med 2021;19:313. [PMID: 34879839 DOI: 10.1186/s12916-021-02185-0] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
83 Kalantar-Zadeh K, Beddhu S, Kovesdy CP, Kramer HJ, Fouque D. Biologically plausible trends suggesting that a low-protein diet may enhance the effect of flozination caused by the sodium-glucose cotransporter-2 inhibitor dapagliflozin on albuminuria. Diabetes Obes Metab 2021;23:2825-6. [PMID: 34387935 DOI: 10.1111/dom.14524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Säemann M, Kronbichler A. Call for action in ANCA-associated vasculitis and lupus nephritis: promises and challenges of SGLT-2 inhibitors. Ann Rheum Dis 2021:annrheumdis-2021-221474. [PMID: 34844933 DOI: 10.1136/annrheumdis-2021-221474] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
85 Gregorich M, Heinzel A, Kammer M, Meiselbach H, Böger C, Eckardt KU, Mayer G, Heinze G, Oberbauer R. A prediction model for the decline in renal function in people with type 2 diabetes mellitus: study protocol. Diagn Progn Res 2021;5:19. [PMID: 34789343 DOI: 10.1186/s41512-021-00107-5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
86 Chaudhuri A, Ghanim H, Arora P. Improving the residual risk of renal and cardiovascular outcomes in diabetic kidney disease: A review of pathophysiology, mechanisms, and evidence from recent trials. Diabetes Obes Metab 2021. [PMID: 34779091 DOI: 10.1111/dom.14601] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
87 Murea M, Deira J, Kalantar-Zadeh K, Casino FG, Basile C. The spectrum of kidney dysfunction requiring chronic dialysis therapy: Implications for clinical practice and future clinical trials. Semin Dial 2021. [PMID: 34643003 DOI: 10.1111/sdi.13027] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
88 Lin CH, Tseng HF, Hsieh PC, Chiu V, Lin TY, Lan CC, Tzeng IS, Chao HN, Hsu CC, Kuo CY. Nephroprotective Role of Chrysophanol in Hypoxia/Reoxygenation-Induced Renal Cell Damage via Apoptosis, ER Stress, and Ferroptosis. Biomedicines 2021;9:1283. [PMID: 34572468 DOI: 10.3390/biomedicines9091283] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
89 Oguz F, Demoulin N, Thissen JP, Jadoul M, Morelle J. Inhibition of sodium-glucose cotransporter 2 to slow the progression of chronic kidney disease. Acta Clin Belg 2021;:1-10. [PMID: 34404335 DOI: 10.1080/17843286.2021.1966583] [Cited by in F6Publishing: 1] [Reference Citation Analysis]